Professional Documents
Culture Documents
Airflow Disorders
Airflow Disorders
Beta2 ‑adrenergic agonists ●● Instruct clients to check pulse and to report an increase
of greater than 20 to 30 beats/min.
SELECT PROTOTYPE MEDICATION: Albuterol ●● Advise clients to avoid caffeine.
●● Dosage might need to be reduced.
OTHER MEDICATIONS
●● Formoterol
Tremors
●● Levalbuterol
●● Salmeterol Caused by activation of beta2 receptors in skeletal muscle
●● Terbutaline
NURSING CONSIDERATIONS
●● Tremors usually resolve with continued medication use.
Dosage might need to be reduced.
PURPOSE
●●
●● When a client has prescriptions for an inhaled ●● Resolution of asthma exacerbations as evidenced by
beta2‑agonist and an inhaled glucocorticoid, advise absence of shortness of breath, clear breath sounds,
the client to inhale the beta2‑agonist before inhaling absence of wheezing, and return of respiratory rate
the glucocorticoid. The beta2‑agonist promotes to baseline
bronchodilation and enhances absorption of
the glucocorticoid.
●●
●●
Advise clients not to exceed prescribed dosages.
Ensure that clients know the dosage schedule
Methylxanthines
(if the medication is to be taken on a fixed or SELECT PROTOTYPE MEDICATION: Theophylline
as‑needed schedule).
●● Formoterol and salmeterol are long‑acting beta2‑agonist
inhalers. These inhalers are used every 12 hr for PURPOSE
long‑term control and are not used to abort an asthma
EXPECTED PHARMACOLOGICAL ACTION
attack, or exacerbation. These long‑acting agents are ●● Relaxation of bronchial smooth muscle, resulting
not used alone but are prescribed in combination with
in bronchodilation
an inhaled glucocorticoid. ●● Once the first‑line medication for asthma, now used
infrequently because newer medications are safer and
more effective
COMPLICATIONS
Mild toxicity reaction can include
GI distress and restlessness.
More severe reactions can occur with higher therapeutic
levels and can include dysrhythmias and seizures.
NURSING CONSIDERATIONS
●● Monitor theophylline serum levels to keep within
therapeutic range (5 to 15 mcg/mL). Adverse effects are
unlikely to occur at levels less than 20 mcg/mL.
●● If manifestations occur, stop the medication. Activated
charcoal is used to decrease absorption, lidocaine is
used to treat dysrhythmias, and diazepam is used to
control seizures.
●● Instruct client that periodic monitoring of blood levels
is needed. Advise client to report nausea, diarrhea, or
restlessness, which are indicative of toxicity.
NURSING EVALUATION OF
MEDICATION EFFECTIVENESS
Depending on therapeutic intent, effectiveness is
evidenced by the following.
●● Control of bronchospasm in clients who have COPD
exercise‑induced bronchospasm
dosing schedule.
◯◯ Mometasone and formoterol
●● Monitor blood glucose levels.
●● Oral: prednisolone ●● Taper the dose. Do not stop abruptly.
●● IV
◯◯ Hydrocortisone
◯◯ Methylprednisolone
Bone loss
Can occur with inhaled agents and oral agents
NURSING CONSIDERATIONS
PURPOSE ●● Advise clients to perform weight‑bearing exercises.
EXPECTED PHARMACOLOGICAL ACTION ●● Advise clients to consume a diet with sufficient calcium
●● Prevent inflammation, suppress airway mucus and vitamin D intake.
production, and promote responsiveness of beta 2 ●● Use the lowest dose possible to control manifestations.
receptors in the bronchial tree ●● Oral medications should be given on an alternate‑day
●● Reduction in airway mucosa edema dosing schedule.
diabetes mellitus, hypertension, heart failure, peptic ●● Resolution of acute exacerbation as demonstrated by
ulcer disease, osteoporosis, and/or kidney dysfunction. absence of shortness of breath, clear breath sounds,
absence of wheezing, and return of respiratory rate
to baseline
INTERACTIONS
Prednisone
Leukotriene modifiers
Concurrent use of potassium‑depleting diuretics
SELECT PROTOTYPE MEDICATION: Montelukast
increases the risk of hypokalemia.
NURSING CONSIDERATIONS: Monitor potassium level and OTHER MEDICATIONS
administer supplements as needed. ●● Zileuton
●● Zafirlukast
Concurrent use of NSAIDs increases the risk of
GI ulceration.
NURSING CONSIDERATIONS: Advise clients to avoid use
of NSAIDs. If GI distress occurs, instruct clients to notify
PURPOSE
the provider. EXPECTED PHARMACOLOGICAL ACTION: Leukotriene
modifiers suppress the effects of leukotrienes, thereby
Concurrent use of glucocorticoids and hypoglycemic
reducing inflammation, bronchoconstriction, airway
agents (oral and insulin) counteract the effects.
edema, and mucus production.
NURSING CONSIDERATIONS: Clients should notify the
provider if hyperglycemia occurs. The client might need THERAPEUTIC USES: Long‑term therapy of asthma in
increased dosage of insulin or oral hypoglycemics. adults and children, and to prevent exercise‑induced
bronchospasm
●● Montelukast is used in children as young as 12 months
NCLEX® Connection: Pharmacological and Parenteral Therapies, 4. A. CORRECT: Weight gain and fluid retention are adverse effects of
Medication Administration oral prednisone due to the effect of sodium and water retention.
B. Nervousness and insomnia are adverse effects
2. A. Albuterol is a short acting inhaled beta2‑agonist and of beta agonists, not glucocorticoids.
used for short term relief of bronchospasm.
C. Tachycardia are adverse effects of prednisone and beta agonists.
B. CORRECT: When a client is prescribed an inhaled beta2‑agonist (such
as albuterol) and an inhaled glucocorticoid (such as beclomethasone), D. Diarrhea is an adverse effect of prednisone.
the client should take the beta2‑agonist first. The beta2‑agonist promotes Constipation is an adverse effect of tiotropium.
bronchodilation and enhances absorption of the glucocorticoid.
NCLEX® Connection: Pharmacological and Parenteral Therapies,
C. Beclomethasone is administered on a fixed Adverse Effects/Contraindications/Side Effects/Interactions
schedule. It is not used to treat an acute attack.
D. The client should shake the metered dose
inhaler well before administration.
PRACTICE Answer